Barclays’s Nutriband NTRB Stock Holding History

Barclays’s Portfolio NTRB Stock Details NTRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61	Buy	+19	New	+$69	﹤0.01%	5226
2025 Q4	–	Sell	-18	Closed	-$127	–	5543
2025 Q3	$127	Buy	+18	New	+$131	﹤0.01%	5262

Other funds holding NTRB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Haven Private Orlando, Florida $263M AUM 21.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Barclays's NTRB Position: Q2 2026 in Review

Barclays opened a new position in Nutriband (NTRB) in Q2 2026: 19 shares worth $61. The stake represents ﹤0.01% of the portfolio and ranks #5226 among its holdings. This is a return to the name: Barclays previously reported a position in NTRB as recently as Q3 2025.

Barclays first reported a position in NTRB in Q3 2025 and has held it in 2 quarters since. The position peaked at $127 in Q3 2025. 16 funds tracked by Wall St. Rank hold NTRB as of Q2 2026.

Barclays held 19 shares of Nutriband worth $61 as of Q2 2026.
Nutriband was a new Barclays position in Q2 2026.
Nutriband made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5226 holding.
Barclays first reported a position in Nutriband in Q3 2025 and has held it in 2 quarters since.
Barclays's Nutriband position peaked at $127 in Q3 2025.
16 funds tracked by Wall St. Rank held Nutriband as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.